These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 25996499)

  • 41. The challenges of multi-drug-resistance in hepatology.
    Fernández J; Bert F; Nicolas-Chanoine MH
    J Hepatol; 2016 Nov; 65(5):1043-1054. PubMed ID: 27544545
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria.
    Pontikis K; Karaiskos I; Bastani S; Dimopoulos G; Kalogirou M; Katsiari M; Oikonomou A; Poulakou G; Roilides E; Giamarellou H
    Int J Antimicrob Agents; 2014 Jan; 43(1):52-9. PubMed ID: 24183799
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The impact of an antibiotic cycling program on empirical therapy for gram-negative infections.
    Merz LR; Warren DK; Kollef MH; Fridkin SK; Fraser VJ
    Chest; 2006 Dec; 130(6):1672-8. PubMed ID: 17166981
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates--a multicentre, observational survey in critically ill patients.
    Vogelaers D; De Bels D; Forêt F; Cran S; Gilbert E; Schoonheydt K; Blot S;
    Int J Antimicrob Agents; 2010 Apr; 35(4):375-81. PubMed ID: 20122817
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High Prevalence of Multidrug Resistant Bacteria in Cirrhotic Patients with Spontaneous Bacterial Peritonitis: Is It Time to Change the Standard Antimicrobial Approach?
    Oliveira JC; Carrera E; Petry RC; Deutschendorf C; Mantovani A; Barcelos STA; Cassales S; Schacher FC; Lopes AB; Alvares-da-Silva MR
    Can J Gastroenterol Hepatol; 2019; 2019():6963910. PubMed ID: 31214551
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia.
    Chung DR; Song JH; Kim SH; Thamlikitkul V; Huang SG; Wang H; So TM; Yasin RM; Hsueh PR; Carlos CC; Hsu LY; Buntaran L; Lalitha MK; Kim MJ; Choi JY; Kim SI; Ko KS; Kang CI; Peck KR;
    Am J Respir Crit Care Med; 2011 Dec; 184(12):1409-17. PubMed ID: 21920919
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epidemiology and Risk Factors for Isolation of Multi-Drug-Resistant Organisms in Patients with Complicated Intra-Abdominal Infections.
    Labricciosa FM; Sartelli M; Abbo LM; Barbadoro P; Ansaloni L; Coccolini F; Catena F
    Surg Infect (Larchmt); 2018 Apr; 19(3):264-272. PubMed ID: 29298133
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bacterial infections and hepatic encephalopathy in liver cirrhosis-prophylaxis and treatment.
    Piotrowski D; Boroń-Kaczmarska A
    Adv Med Sci; 2017 Sep; 62(2):345-356. PubMed ID: 28514703
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intestinal colonization with resistant bacteria: a prognostic marker of mortality in decompensated cirrhosis.
    Pouriki S; Vrioni G; Sambatakou H; Alexopoulou A; Vasilieva L; Mani I; Tsakris A; Dourakis SP
    Eur J Clin Microbiol Infect Dis; 2018 Jan; 37(1):127-134. PubMed ID: 28963603
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Spontaneous bacterial peritonitis and extraperitoneal infections in patients with cirrhosis.
    Mattos AA; Wiltgen D; Jotz RF; Dornelles CMR; Fernandes MV; Mattos ÂZ
    Ann Hepatol; 2020; 19(5):451-457. PubMed ID: 32533951
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia.
    Aliberti S; Di Pasquale M; Zanaboni AM; Cosentini R; Brambilla AM; Seghezzi S; Tarsia P; Mantero M; Blasi F
    Clin Infect Dis; 2012 Feb; 54(4):470-8. PubMed ID: 22109954
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High prevalence of antibiotic-resistant bacterial infections among patients with cirrhosis at a US liver center.
    Tandon P; Delisle A; Topal JE; Garcia-Tsao G
    Clin Gastroenterol Hepatol; 2012 Nov; 10(11):1291-8. PubMed ID: 22902776
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bacteremia in Patients With Liver Cirrhosis: Prevalence and Predictors of Multidrug Resistant Organisms.
    Addo Smith JN; Yau R; Russo HP; Putney K; Restrepo A; Garey KW; Sofjan AK
    J Clin Gastroenterol; 2018 Aug; 52(7):648-654. PubMed ID: 29176351
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bloodstream infections caused by multi-drug resistant Proteus mirabilis: Epidemiology, risk factors and impact of multi-drug resistance.
    Korytny A; Riesenberg K; Saidel-Odes L; Schlaeffer F; Borer A
    Infect Dis (Lond); 2016; 48(6):428-31. PubMed ID: 26763474
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia.
    Bassetti M; Trecarichi EM; Mesini A; Spanu T; Giacobbe DR; Rossi M; Shenone E; Pascale GD; Molinari MP; Cauda R; Viscoli C; Tumbarello M
    Clin Microbiol Infect; 2012 Sep; 18(9):862-9. PubMed ID: 21999245
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Resistance to antibiotics: are we in the post-antibiotic era?
    Alanis AJ
    Arch Med Res; 2005; 36(6):697-705. PubMed ID: 16216651
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New antimicrobial agents for the treatment of bacterial infections in cancer patients.
    Rolston KV
    Hematol Oncol; 2009 Sep; 27(3):107-14. PubMed ID: 19569253
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Microbiological surveillance and antimicrobial stewardship minimise the need for ultrabroad-spectrum combination therapy for treatment of nosocomial infections in a trauma intensive care unit: an audit of an evidence-based empiric antimicrobial policy.
    Ramsamy Y; Muckart DJ; Han KS
    S Afr Med J; 2013 Mar; 103(6):371-6. PubMed ID: 23725954
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of bacterial infections in cirrhosis.
    Fernández J; Gustot T
    J Hepatol; 2012; 56 Suppl 1():S1-12. PubMed ID: 22300459
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antimicrobial resistance in gram-positive bacteria.
    Rice LB
    Am J Infect Control; 2006 Jun; 34(5 Suppl 1):S11-9; discussion S64-73. PubMed ID: 16813977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.